ZMYND8 and Miyoshi myopathy: Furthermore, we explored the impact of ZMYND8 expression on the sensitivity of MM cells to PIs and found that ZMYND8 overexpression significantly enhanced the antimyeloma effect of carfilzomib (CFZ), which is expected to support the development of novel clinical therapies.